Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Turkbey Website

Ismail Baris Turkbey, M.D.

Selected Publications

1)  Bhutani M, Turkbey B, Tan E, Kemp TJ, Pinto LA, Berg AR, Korde N, Minter AR, Weiss BM, Mena E, Lindenberg L, Aras O, Purdue MP, Hofmann JN, Steinberg SM, Calvo KR, Choyke PL, Maric I, Kurdziel K, Landgren O.
Bone marrow angiogenesis in myeloma and its precursor disease: a prospective clinical trial.
Leukemia. 28: 413-6, 2014.
2)  Logan JK, Walton-Diaz A, Rais-Bahrami S, Merino MJ, Turkbey B, Choyke PL, Pinto PA.
Changes observed in multiparametric prostate magnetic resonance imaging characteristics correlate with histopathological development of chronic granulomatous prostatitis after intravesical bacillus calmette-guerin therapy.
J Comput Assist Tomogr. 38: 274-6, 2014.
3)  Garvey B, Türkbey B, Truong H, Bernardo M, Periaswamy S, Choyke PL.
Clinical value of prostate segmentation and volume determination on MRI in benign prostatic hyperplasia.
Diagn Interv Radiol. [Epub ahead of print], 2014.
4)  Rais-Bahrami S, Siddiqui MM, Vourganti S, Turkbey B, Rastinehad AR, Stamatakis L, Truong H, Walton-Diaz A, Hoang AN, Nix JW, Merino MJ, Wood BJ, Simon RM, Choyke PL, Pinto PA.
Diagnostic Value of Biparametric MRI as an Adjunct to PSA-based Detection of Prostate Cancer in Men without Prior Biopsies.
BJU Int. [Epub ahead of print], 2014.
5)  Hong CW, Walton-Diaz A, Rais-Bahrami S, Hoang AN, Türkbey B, Stamatakis L, Xu S, Amalou H, Siddiqui MM, Nix JW, Vourganti S, Merino MJ, Choyke PL, Wood BJ, Pinto PA.
Imaging and pathology findings after an initial negative MRI-US fusion-guided and 12-core extended sextant prostate biopsy session.
Diagn Interv Radiol. [Epub ahead of print], 2014.
6)  Turkbey B, Mena E, Shih J, Pinto PA, Merino MJ, Lindenberg ML, Bernardo M, McKinney YL, Adler S, Owenius R, Choyke PL, Kurdziel KA.
Localized prostate cancer detection with 18F FACBC PET/CT: comparison with MR imaging and histopathologic analysis.
Radiology. 270: 849-56, 2014.
7)  Turkbey B, Kobayashi H, Hoyt RF, Choyke PL, Nakajima T, Griffiths GL, Bernardo M, Rialon K, Fishman SJ, Sena LM.
Magnetic resonance lymphography of the thoracic duct after interstitial injection of gadofosveset trisodium: a pilot dosing study in a porcine model.
Lymphat Res Biol. 12: 32-6, 2014.
8)  Johnson LM, Rothwax JT, Turkbey B, Rais-Bahrami S, Wood BJ, Figg WD, Choyke PL, Merino MJ, Pinto PA.
Multiparametric Magnetic Resonance Imaging of the Prostate Aids to Detect Lesion Progression.
J Comput Assist Tomogr. [Epub ahead of print], 2014.
9)  Volkin D, Turkbey B, Hoang AN, Rais-Bahrami S, Yerram N, Walton-Diaz A, Nix JW, Wood BJ, Choyke PL, Pinto PA.
Multiparametric MRI and Subsequent MR/Ultrasound Fusion-Guided Biopsy Increase the Detection of Anteriorly Located Prostate Cancers.
BJU Int. [Epub ahead of print], 2014.
10)  Jeong W, Rapisarda A, Park SR, Kinders RJ, Chen A, Melillo G, Turkbey B, Steinberg SM, Choyke P, Doroshow JH, Kummar S.
Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1a), in patients with refractory solid tumors.
Cancer Chemother. Pharmacol. 73: 343-8, 2014.
11)  Hong CW, Amalou H, Xu S, Turkbey B, Yan P, Kruecker J, Pinto PA, Choyke PL, Wood BJ.
Prostate Biopsy for the Interventional Radiologist.
J Vasc Interv Radiol. [Epub ahead of print], 2014.
12)  Rais-Bahrami S, Turkbey B, Grant KB, Pinto PA, Choyke PL.
Role of multiparametric magnetic resonance imaging in the diagnosis of prostate cancer.
Curr Urol Rep. 15: 387, 2014.
13)  Smedley J, Turkbey B, Bernardo ML, Del Prete GQ, Estes JD, Griffiths GL, Kobayashi H, Choyke PL, Lifson JD, Keele BF.
Tracking the Luminal Exposure and Lymphatic Drainage Pathways of Intravaginal and Intrarectal Inocula Used in Nonhuman Primate Models of HIV Transmission.
PLoS ONE. 9: e92830, 2014.
14)  Jeong W, Park SR, Rapisarda A, Fer N, Kinders RJ, Chen A, Melillo G, Turkbey B, Steinberg SM, Choyke P, Doroshow JH, Kummar S.
Weekly EZN-2208 (PEGylated SN-38) in combination with bevacizumab in patients with refractory solid tumors.
Invest New Drugs. 32: 340-6, 2014.
15)  Stamatakis L, Siddiqui MM, Nix JW, Logan J, Rais-Bahrami S, Walton-Diaz A, Hoang AN, Vourganti S, Truong H, Shuch B, Parnes HL, Turkbey B, Choyke PL, Wood BJ, Simon RM, Pinto PA.
Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer.
Cancer. 119: 3359-66, 2013.
16)  Walton Diaz A, Hoang AN, Turkbey B, Hong CW, Truong H, Sterling T, Rais-Bahrami S, Siddiqui MM, Stamatakis L, Vourganti S, Nix J, Logan J, Harris C, Weintraub M, Chua C, Merino MJ, Choyke P, Wood BJ, Pinto PA.
Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates?.
J. Urol. 190: 2020-5, 2013.
17)  Gunay-Aygun M, Font-Montgomery E, Lukose L, Tuchman Gerstein M, Piwnica-Worms K, Choyke P, Daryanani KT, Turkbey B, Fischer R, Bernardini I, Sincan M, Zhao X, Sandler NG, Roque A, Douek DC, Graf J, Huizing M, Bryant JC, Mohan P, Gahl WA, Heller T.
Characteristics of congenital hepatic fibrosis in a large cohort of patients with autosomal recessive polycystic kidney disease.
Gastroenterology. 144: 112-121.e2, 2013.
18)  Turkbey B, Merino MJ, Gallardo EC, Shah V, Aras O, Bernardo M, Mena E, Daar D, Rastinehad AR, Linehan WM, Wood BJ, Pinto PA, Choyke PL.
Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: Correlation with whole-mount histopathology.
J Magn Reson Imaging. [Epub ahead of print], 2013.
19)  Logan JK, Rais-Bahrami S, Turkbey B, Gomella A, Amalou H, Choyke PL, Wood BJ, Pinto PA.
Current Status of MRI and Ultrasound Fusion Software Platforms for Guidance of Prostate Biopsies.
BJU Int. [Epub ahead of print], 2013.
20)  Wood BJ, Choyke P, Turkbey B, Pinto P.
Editorial comment.
J. Urol. 189: 92, 2013.
21)  Turkbey B, Fotin SV, Huang RJ, Yin Y, Daar D, Aras O, Bernardo M, Garvey BE, Weaver J, Haldankar H, Muradyan N, Merino MJ, Pinto PA, Periaswamy S, Choyke PL.
Fully automated prostate segmentation on MRI: comparison with manual segmentation methods and specimen volumes.
AJR Am J Roentgenol. 201: W720-9, 2013.
22)  Grant K, Lindenberg ML, Shebel H, Pang Y, Agarwal HK, Bernardo M, Kurdziel KA, Turkbey B, Choyke PL.
Functional and molecular imaging of localized and recurrent prostate cancer.
Eur. J. Nucl. Med. Mol. Imaging. 40 Suppl 1: S48-59, 2013.
23)  Turkbey B, Mena E, Aras O, Garvey B, Grant K, Choyke PL.
Functional and molecular imaging: applications for diagnosis and staging of localised prostate cancer.
Clin Oncol (R Coll Radiol). 25: 451-60, 2013.
24)  Rastinehad AR, Turkbey B, Salami SS, Yaskiv O, George AK, Fakhoury M, Beecher K, Vira MA, Kavoussi LR, Siegel DN, Villani R, Ben-Levi E.
Improving Detection of Clinically Significant Prostate Cancer: Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Guided Prostate Biopsy.
J. Urol. [Epub ahead of print], 2013.
25)  Pang Y, Turkbey B, Bernardo M, Kruecker J, Kadoury S, Merino MJ, Wood BJ, Pinto PA, Choyke PL.
Intravoxel incoherent motion MR imaging for prostate cancer: an evaluation of perfusion fraction and diffusion coefficient derived from different b-value combinations.
Magn Reson Med. 69: 553-62, 2013.
26)  Partanen A, Yerram NK, Trivedi H, Dreher MR, Oila J, Hoang AN, Volkin D, Nix J, Turkbey B, Bernardo M, Haines DC, Benjamin CJ, Linehan WM, Choyke P, Wood BJ, Ehnholm GJ, Venkatesan AM, Pinto PA.
Magnetic resonance imaging (MRI)-guided transurethral ultrasound therapy of the prostate: a preclinical study with radiological and pathological correlation using customised MRI-based moulds.
BJU Int. 112: 508-16, 2013.
27)  Siddiqui MM, Rais-Bahrami S, Truong H, Stamatakis L, Vourganti S, Nix J, Hoang AN, Walton-Diaz A, Shuch B, Weintraub M, Kruecker J, Amalou H, Turkbey B, Merino MJ, Choyke PL, Wood BJ, Pinto PA.
Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy.
Eur. Urol. 64: 713-9, 2013.
28)  Nakajima T, Turkbey B, Sano K, Sato K, Bernardo M, Hoyt RF, Choyke PL, Kobayashi H.
MR lymphangiography with intradermal gadofosveset and human serum albumin in mice and primates.
J Magn Reson Imaging. [Epub ahead of print], 2013.
29)  Truong H, Logan J, Turkbey B, Siddiqui MM, Rais-Bahrami S, Hoang AN, Pusateri C, Shuch B, Walton-Diaz A, Vourganti S, Nix J, Stamatakis L, Harris C, Chua C, Choyke PL, Wood BJ, Pinto PA.
MRI characterization of the dynamic effects of 5a-reductase inhibitors on prostate zonal volumes.
Can J Urol. 20: 7002-7, 2013.
30)  Kim A, Dombi E, Tepas K, Fox E, Martin S, Wolters P, Balis FM, Jayaprakash N, Turkbey B, Muradyan N, Choyke PL, Reddy A, Korf B, Widemann BC.
Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas.
Pediatr Blood Cancer. 60: 396-401, 2013.
31)  Turkbey B, Mani H, Aras O, Ho J, Hoang A, Rastinehad AR, Agarwal H, Shah V, Bernardo M, Pang Y, Daar D, McKinney YL, Linehan WM, Kaushal A, Merino MJ, Wood BJ, Pinto PA, Choyke PL.
Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance?.
Radiology. 268: 144-52, 2013.
32)  Yang M, Li X, Turkbey B, Choyke PL, Yan P.
Prostate segmentation in MR images using discriminant boundary features.
IEEE Trans Biomed Eng. 60: 479-88, 2013.
33)  Ho J, Turkbey B, Edgerly M, Alimchandani M, Quezado M, Camphausen K, Fojo T, Kaushal A.
Role of radiotherapy in adrenocortical carcinoma.
Cancer J. 19: 288-94, 2013.
34)  Moore CM, Kasivisvanathan V, Eggener S, Emberton M, Fütterer JJ, Gill IS, Grubb Iii RL, Hadaschik B, Klotz L, Margolis DJ, Marks LS, Melamed J, Oto A, Palmer SL, Pinto P, Puech P, Punwani S, Rosenkrantz AB, Schoots IG, Simon R, Taneja SS, Turkbey B, Ukimura O, van der Meulen J, Villers A, Watanabe Y.
Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group.
Eur. Urol. 64: 544-52, 2013.
35)  Choyke PL, Turkbey B.
The state of prostate MRI in 2013: into the breach.
Oncology (Williston Park, N.Y.). 27: 274, 276, 2013.
36)  Rais-Bahrami S, Siddiqui MM, Turkbey B, Stamatakis L, Logan J, Hoang AN, Walton-Diaz A, Vourganti S, Truong H, Kruecker J, Merino MJ, Wood BJ, Choyke PL, Pinto PA.
Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer.
J. Urol. 190: 1721-7, 2013.
37)  Mena E, Turkbey B, Mani H, Adler S, Valera VA, Bernardo M, Shah V, Pohida T, McKinney Y, Kwarteng G, Daar D, Lindenberg ML, Eclarinal P, Wade R, Linehan WM, Merino MJ, Pinto PA, Choyke PL, Kurdziel KA.
11C-Acetate PET/CT in localized prostate cancer: a study with MRI and histopathologic correlation.
J. Nucl. Med. 53: 538-45, 2012.
38)  Tahmasebi AM, Sharifi R, Agarwal HK, Turkbey B, Bernardo M, Choyke P, Pinto P, Wood B, Kruecker J.
A statistical model-based technique for accounting for prostate gland deformation in endorectal coil-based MR imaging.
Conf Proc IEEE Eng Med Biol Soc. 2012: 5412-5, 2012.
39)  Singer EA, Kaushal A, Turkbey B, Couvillon A, Pinto PA, Parnes HL.
Active surveillance for prostate cancer: past, present and future.
Curr Opin Oncol. 24: 243-50, 2012.
40)  Turkbey B, Huang R, Vourganti S, Trivedi H, Bernardo M, Yan P, Benjamin C, Pinto PA, Choyke PL.
Age-related changes in prostate zonal volumes as measured by high-resolution magnetic resonance imaging (MRI): a cross-sectional study in over 500 patients.
BJU Int. 110: 1642-7, 2012.
41)  Turkbey B, Mani H, Aras O, Rastinehad AR, Shah V, Bernardo M, Pohida T, Daar D, Benjamin C, McKinney YL, Linehan WM, Wood BJ, Merino MJ, Choyke PL, Pinto PA.
Correlation of magnetic resonance imaging tumor volume with histopathology.
J. Urol. 188: 1157-63, 2012.
42)  Shah V, Turkbey B, Mani H, Pang Y, Pohida T, Merino MJ, Pinto PA, Choyke PL, Bernardo M.
Decision support system for localizing prostate cancer based on multiparametric magnetic resonance imaging.
Med Phys. 39: 4093-103, 2012.
43)  Lim J, Turkbey B, Bernardo M, Bryant LH, Garzoni M, Pavan GM, Nakajima T, Choyke PL, Simanek EE, Kobayashi H.
Gadolinium MRI contrast agents based on triazine dendrimers: relaxivity and in vivo pharmacokinetics.
Bioconjug. Chem. 23: 2291-9, 2012.
44)  Wang S, Liu P, Turkbey B, Choyke P, Pinto P, Summers RM.
Gaussian process inference for estimating pharmacokinetic parameters of dynamic contrast-enhanced MR images.
Med Image Comput Comput Assist Interv. 15: 582-9, 2012.
45)  Yerram NK, Volkin D, Turkbey B, Nix J, Hoang AN, Vourganti S, Gupta GN, Linehan WM, Choyke PL, Wood BJ, Pinto PA.
Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancer.
BJU Int. 110: E783-8, 2012.
46)  Vourganti S, Rastinehad A, Yerram NK, Nix J, Volkin D, Hoang A, Turkbey B, Gupta GN, Kruecker J, Linehan WM, Choyke PL, Wood BJ, Pinto PA.
Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies.
J. Urol. 188: 2152-7, 2012.
47)  Turkbey B, Choyke PL.
Multiparametric MRI and prostate cancer diagnosis and risk stratification.
Curr Opin Urol. 22: 310-5, 2012.
48)  Verma S, Turkbey B, Muradyan N, Rajesh A, Cornud F, Haider MA, Choyke PL, Harisinghani M.
Overview of dynamic contrast-enhanced MRI in prostate cancer diagnosis and management.
AJR Am J Roentgenol. 198: 1277-88, 2012.
49)  Bouchelouche K, Turkbey B, Choyke PL.
PET/CT and MRI in Bladder Cancer.
J Cancer Sci Ther. S14, 2012.
50)  Histed SN, Lindenberg ML, Mena E, Turkbey B, Choyke PL, Kurdziel KA.
Review of functional/anatomical imaging in oncology.
Nucl Med Commun. 33: 349-61, 2012.
51)  Kurdziel KA, Shih JH, Apolo AB, Lindenberg L, Mena E, McKinney YY, Adler SS, Turkbey B, Dahut W, Gulley JL, Madan RA, Landgren O, Choyke PL.
The kinetics and reproducibility of 18F-sodium fluoride for oncology using current PET camera technology.
J. Nucl. Med. 53: 1175-84, 2012.
52)  Trivedi H, Turkbey B, Rastinehad AR, Benjamin CJ, Bernardo M, Pohida T, Shah V, Merino MJ, Wood BJ, Linehan WM, Venkatesan AM, Choyke PL, Pinto PA.
Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer.
Urology. 79: 233-9, 2012.
53)  Nix JW, Turkbey B, Hoang A, Volkin D, Yerram N, Chua C, Linehan WM, Wood B, Choyke P, Pinto PA.
Very distal apical prostate tumours: identification on multiparametric MRI at 3 Tesla.
BJU Int. 110: E694-700, 2012.
54)  Turcotte S, Turkbey B, Barak S, Libutti SK, Alexander HR, Linehan WM, Hughes MS, Nilubol N, Gesuwan K, Millo C, Quezado M, Choyke PL, Kebebew E, Phan GQ.
von Hippel-Lindau disease-associated solid microcystic serous adenomas masquerading as pancreatic neuroendocrine neoplasms.
Surgery. 152: 1106-17, 2012.
55)  Liu W, Turkbey B, Sénégas J, Remmele S, Xu S, Kruecker J, Bernardo M, Wood BJ, Pinto PA, Choyke PL.
Accelerated T2 mapping for characterization of prostate cancer.
Magn Reson Med. 65: 1400-6, 2011.
56)  Yan P, Xu S, Turkbey B, Kruecker J.
Adaptively learning local shape statistics for prostate segmentation in ultrasound.
IEEE Trans Biomed Eng. 58: 633-41, 2011.
57)  Rastinehad AR, Baccala AA, Chung PH, Proano JM, Kruecker J, Xu S, Locklin JK, Turkbey B, Shih J, Bratslavsky G, Linehan WM, Glossop ND, Yan P, Kadoury S, Choyke PL, Wood BJ, Pinto PA.
D'Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging.
J. Urol. 185: 815-20, 2011.
58)  Kojima C, Turkbey B, Ogawa M, Bernardo M, Regino CA, Bryant LH, Choyke PL, Kono K, Kobayashi H.
Dendrimer-based MRI contrast agents: the effects of PEGylation on relaxivity and pharmacokinetics.
Nanomedicine : nanotechnology, biology, and medicine. 2011.
59)  Turkbey B, Aras O, Karabulut N, Turgut AT, Akpinar E, Alibek S, Pang Y, Erturk SM, El Khouli RH, Bluemke DA, Choyke PL.
Diffusion-weighted MRI for detecting and monitoring cancer: a review of current applications in body imaging.
Diagnostic and interventional radiology (Ankara, Turkey). 2011.
60)  Turkbey B, Xu S, Kruecker J, Locklin J, Pang Y, Bernardo M, Merino MJ, Wood BJ, Choyke PL, Pinto PA.
Documenting the location of prostate biopsies with image fusion.
BJU Int. 107: 53-7, 2011.
61)  Turkbey B, Xu S, Kruecker J, Locklin J, Pang Y, Shah V, Bernardo M, Baccala A, Rastinehad A, Benjamin C, Merino MJ, Wood BJ, Choyke PL, Pinto PA.
Documenting the location of systematic transrectal ultrasound-guided prostate biopsies: correlation with multi-parametric MRI.
Cancer Imaging. 11: 31-6, 2011.
62)  Kelly RJ, Rajan A, Force J, Lopez-Chavez A, Keen C, Cao L, Yu Y, Choyke P, Turkbey B, Raffeld M, Xi L, Steinberg SM, Wright JJ, Kummar S, Gutierrez M, Giaccone G.
Evaluation of KRAS mutations, angiogenic biomarkers, and DCE-MRI in patients with advanced non-small-cell lung cancer receiving sorafenib.
Clin. Cancer Res. 17: 1190-9, 2011.
63)  Gunay-Aygun M, Turkbey BI, Bryant J, Daryanani KT, Gerstein MT, Piwnica-Worms K, Choyke P, Heller T, Gahl WA.
Hepatorenal findings in obligate heterozygotes for autosomal recessive polycystic kidney disease.
Mol. Genet. Metab. 104: 677-81, 2011.
64)  Turkbey B, Shah VP, Pang Y, Bernardo M, Xu S, Kruecker J, Locklin J, Baccala AA, Rastinehad AR, Merino MJ, Shih JH, Wood BJ, Pinto PA, Choyke PL.
Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images?.
Radiology. 258: 488-95, 2011.
65)  Pinto PA, Chung PH, Rastinehad AR, Baccala AA, Kruecker J, Benjamin CJ, Xu S, Yan P, Kadoury S, Chua C, Locklin JK, Turkbey B, Shih JH, Gates SP, Buckner C, Bratslavsky G, Linehan WM, Glossop ND, Choyke PL, Wood BJ.
Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging.
J. Urol. 186: 1281-5, 2011.
66)  McCann TE, Kosaka N, Turkbey B, Mitsunaga M, Choyke PL, Kobayashi H.
Molecular imaging of tumor invasion and metastases: the role of MRI.
NMR Biomed. 24: 561-8, 2011.
67)  Turkbey B, Bernardo M, Merino MJ, Wood BJ, Pinto PA, Choyke PL.
MRI of localized prostate cancer: coming of age in the PSA era.
Diagnostic and interventional radiology (Ankara, Turkey). 2011.
68)  Kummar S, Raffeld M, Juwara L, Horneffer Y, Strassberger A, Allen D, Steinberg SM, Rapisarda A, Spencer SD, Figg WD, Chen X, Turkbey IB, Choyke P, Murgo AJ, Doroshow JH, Melillo G.
Multihistology, target-driven pilot trial of oral topotecan as an inhibitor of hypoxia-inducible factor-1α in advanced solid tumors.
Clin. Cancer Res. 17: 5123-31, 2011.
69)  Turkbey B, Mani H, Shah V, Rastinehad AR, Bernardo M, Pohida T, Pang Y, Daar D, Benjamin C, McKinney YL, Trivedi H, Chua C, Bratslavsky G, Shih JH, Linehan WM, Merino MJ, Choyke PL, Pinto PA.
Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds.
J. Urol. 186: 1818-24, 2011.
70)  Bouchelouche K, Tagawa ST, Goldsmith SJ, Turkbey B, Capala J, Choyke P.
PET/CT Imaging and Radioimmunotherapy of Prostate Cancer.
Semin Nucl Med. 41: 29-44, 2011.
71)  Kummar S, Gutierrez ME, Chen A, Turkbey IB, Allen D, Horneffer YR, Juwara L, Cao L, Yu Y, Kim YS, Trepel J, Chen H, Choyke P, Melillo G, Murgo AJ, Collins J, Doroshow JH.
Phase I trial of vandetanib and bevacizumab evaluating the VEGF and EGF signal transduction pathways in adults with solid tumours and lymphomas.
Eur. J. Cancer. 47: 997-1005, 2011.
72)  Daar D, Bernardo M, Choyke PL, McKinney Y, Turkbey B.
Prostate multiparameter MR imaging.
Radiol Technol. 82: 563MR-8MR, 2011.
73)  Cao Y, Yuan Y, Li X, Turkbey B, Choyke PL, Yan P.
Segmenting images by combining selected atlases on manifold.
Med Image Comput Comput Assist Interv. 14: 272-9, 2011.
74)  Akcalar S, Turkbey B, Karcaaltincaba M, Akpinar E, Akhan O.
Small bowel wall thickening: MDCT evaluation in the emergency room.
Emerg Radiol. 18: 409-15, 2011.
75)  Gunay-Aygun M, Font-Montgomery E, Lukose L, Tuchman M, Graf J, Bryant JC, Kleta R, Garcia A, Edwards H, Piwnica-Worms K, Adams D, Bernardini I, Fischer RE, Krasnewich D, Oden N, Ling A, Quezado Z, Zak C, Daryanani KT, Turkbey B, Choyke P, Guay-Woodford LM, Gahl WA.
Correlation of kidney function, volume and imaging findings, and PKHD1 mutations in 73 patients with autosomal recessive polycystic kidney disease.
Clin J Am Soc Nephrol. 5: 972-84, 2010.
76)  Yan P, Xu S, Turkbey B, Kruecker J.
Discrete deformable model guided by partial active shape model for TRUS image segmentation.
IEEE Trans Biomed Eng. 57: 1158-66, 2010.
77)  Bouchelouche K, Turkbey B, Choyke P, Capala J.
Imaging prostate cancer: an update on positron emission tomography and magnetic resonance imaging.
Curr Urol Rep. 11: 180-90, 2010.
78)  McCann TE, Kosaka N, Turkbey B, Mitsunaga M, Choyke PL, Kobayashi H.
Molecular imaging of tumor invasion and metastases: the role of MRI.
NMR in biomedicine. 2010.
79)  Ravizzini G, Turkbey B, Barrett T, Kobayashi H, Choyke PL.
Nanoparticles in sentinel lymph node mapping.
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 1: 610-23, 2010.
80)  Turkbey B, Pinto PA, Mani H, Bernardo M, Pang Y, McKinney YL, Khurana K, Ravizzini GC, Albert PS, Merino MJ, Choyke PL.
Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation.
Radiology. 255: 89-99, 2010.
81)  Verma S, Rajesh A, Fütterer JJ, Turkbey B, Scheenen TW, Pang Y, Choyke PL, Kurhanewicz J.
Prostate MRI and 3D MR spectroscopy: how we do it.
AJR Am J Roentgenol. 194: 1414-26, 2010.
82)  Türkbey B, Thomasson D, Pang Y, Bernardo M, Choyke PL.
The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment.
Diagn Interv Radiol. 16: 186-92, 2010.
83)  Shah V, Pohida T, Turkbey B, Mani H, Merino M, Pinto PA, Choyke P, Bernardo M.
A method for correlating in vivo prostate magnetic resonance imaging and histopathology using individualized magnetic resonance-based molds.
Rev Sci Instrum. 80: 104301, 2009.
84)  Turkbey B, Ocak I, Daryanani K, Font-Montgomery E, Lukose L, Bryant J, Tuchman M, Mohan P, Heller T, Gahl WA, Choyke PL, Gunay-Aygun M.
Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis (ARPKD/CHF).
Pediatr Radiol. 39: 100-11, 2009.
85)  Turkbey B, Albert PS, Kurdziel K, Choyke PL.
Imaging localized prostate cancer: current approaches and new developments.
AJR Am J Roentgenol. 192: 1471-80, 2009.
86)  Turkbey B, Kobayashi H, Ogawa M, Bernardo M, Choyke PL.
Imaging of tumor angiogenesis: functional or targeted?.
AJR Am J Roentgenol. 193: 304-13, 2009.
87)  Turkbey B, Pinto PA, Choyke PL.
Imaging techniques for prostate cancer: implications for focal therapy.
Nat Rev Urol. 6: 191-203, 2009.
88)  Gunay-Aygun M, Parisi MA, Doherty D, Tuchman M, Tsilou E, Kleiner DE, Huizing M, Turkbey B, Choyke P, Guay-Woodford L, Heller T, Szymanska K, Johnson CA, Glass I, Gahl WA.
MKS3-related ciliopathy with features of autosomal recessive polycystic kidney disease, nephronophthisis, and Joubert Syndrome.
J. Pediatr. 155: 386-92.e1, 2009.
89)  Lucarelli RT, Ogawa M, Kosaka N, Turkbey B, Kobayashi H, Choyke PL.
New approaches to lymphatic imaging.
Lymphat Res Biol. 7: 205-14, 2009.
90)  Ravizzini G, Turkbey B, Kurdziel K, Choyke PL.
New horizons in prostate cancer imaging.
Eur J Radiol. 70: 212-26, 2009.
91)  Xu S, Kruecker J, Turkbey B, Glossop N, Singh AK, Choyke P, Pinto P, Wood BJ.
Real-time MRI-TRUS fusion for guidance of targeted prostate biopsies.
Comput. Aided Surg. 13: 255-64, 2008.
Click Here to View Collapsed Bibliography.

This page was last updated on 4/16/2014.